European Journal of Internal Medicine
Volume 21, Issue 2 , Pages 62-64 , April 2010

The coagulopathy of chronic liver disease: Is there a causal relationship with bleeding? Yes

Received 22 December 2009 ,Revised 8 January 2010 ,Accepted 12 January 2010.

References 

  1. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981;80:800–809
  2. El-Serag HB, Everhart JE. Improved survival after variceal bleeding over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol. 2000;95:3566–3573
  3. McCormick PA, O'Keefe CO. Improving prognosis following a first variceal haemorrhage over four decades. Gut. 2001;49:682–685
  4. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol. 2003;98:653–659
  5. Reverter JC. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes. J Thromb Haemost. 2006;4:717–720
  6. Boberg KM, Brosstad F, Egeland T, Egge T, Schrumpf E. Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy?. Thromb Haemost. 1999;81:378–381
  7. De Franchis R, Arcidiacono PG, Carpinelli L, Andreoni B, Cestari L, Brunati S, et al. Randomized controlled trial of desmopressin plus terlipressin versus terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club. Hepatology. 1993;18:1102–1107
  8. Basili S, Ferro D, Leo R, Juliano L, Alessandri C, Cordova C, et al. Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis. J Hepatol. 1996;24:574–580
  9. Bosch J, Thabut D, Bendtsen F, D'Amico G, Albillos A, González Abraldes J, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology. 2004;127:1123–1130
  10. Bosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J, et al.  Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology. 2008;47:1604–1614
  11. Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, et al.  Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006;44:1039–1046
  12. Senzolo M, Burra P, Cholongitas E, Burroughs AK. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol. 2006;12:7725–7736
  13. Joist JH. AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state. Am J Gastroenterol. 1999;9:2801–2803
  14. Francis RB, Feinstein DI. Clinical significance of accelerated fibrinolysis in liver disease. Haemostasis. 1984;14:460–465
  15. Bertaglia E, Belmonte P, Vertolli U, Azzurro M, Martines D. Bleeding in cirrhotic patients: a precipitating factor due to intravascular coagulation or to hepatic failure?. Haemostasis. 1983;13:328–334
  16. Violi F, Ferro D, Basili S, Quintarelli C, Saliola M, Alessandri C, et al. Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis. Hepatology. 1992;15:672–676
  17. Violi F, Basili S, Ferro D, Quintarelli C, Alessandril C, Cordova C. Association between high values of d-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group. Thromb Haemost. 1996;76:177–183
  18. Marder VJ, Sherry S. Thrombolytic therapy: current status. N Engl J Med. 1988;16(318):1585–1595
  19. Stricker RB, Wong D, Shiu DT, Reyes PT, Shuman MA. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation. Blood. 1986;68:275–280
  20. Adelman B, Michelson AD, Greenberg J, Handin RI. Proteolysis of platelet glycoprotein Ib by plasmin is facilitated by plasmin lysine-binding regions. Blood. 1986;68:1280–1284
  21. Bosch J, Reverter JC. The coagulopathy of cirrhosis: myth or reality?. Hepatology. 2005;41:434–435
  22. Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology. 1995;108:1828–1834
  23. Violi F, Ferro D, Basili S, Saliola M, Quintarelli C, Alessandri C, et al. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology. 1995;109:531–539
  24. Saliola M, Lorenzet R, Ferro D, Basili S, Caroselli C, Santo AD, et al. Enhanced expression of monocyte tissue factor in patients with liver cirrhosis. Gut. 1998;43:428–432
  25. Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet. 1999;353:139–142
  26. Bernard B, Grangé JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29:1655–1661
  27. Violi F, Ferro D, Basili S, D'Angelo A, Mazzola G, Quintarelli C, et al. Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. BMJ. 1994;309:239–240
  28. Fimognari FL, De Santis A, Piccheri C, Moscatelli R, Gigliotti F, Vestri A, et al. Evaluation of d-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. J Lab Clin Med. 2005;146:238–243
  29. Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Aguirre B, et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology. 1996;23:199–204
  30. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736–741
  31. Violi F, Ferro D, Basili S, Lionetti R, Rossi E, Merli M, et al. Ongoing prothrombotic state in the portal circulation of cirrhotic patients. Thromb Haemost. 1997;77:44–47

PII: S0953-6205(10)00008-7

doi: 10.1016/j.ejim.2010.01.005

European Journal of Internal Medicine
Volume 21, Issue 2 , Pages 62-64 , April 2010

Article Tools

* Image Usage & Resolution